| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Technical Briefs |
1 Department of Biochemistry, National Cardiovascular Center Research Institute, and2 Department of Internal Medicine, National Cardiovascular Center, Osaka 565-8565, Japan;3 Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan
aaddress correspondence to this author at: Department of Biochemistry, National Cardiovascular Center Research Institute, National Cardiovascular Center, Osaka 565-8565, Japan; fax 81-6-6835-5402, e-mail kangawa@ri.ncvc.go.jp
| The first 300 words of the full text of this article appear below. |
Ghrelin is an acylated peptide with growth-hormone-releasing activity (1). It was first isolated from rat and human stomach during the search for an endogenous ligand to the "orphan" G-protein-coupled receptor, growth hormone secretagogue receptor (2). The peptide contains 28 amino acids, and n-octanoylation of the Ser-3 hydroxyl group is necessary for biological activity. Most studies have focused on the somatotropic and orexigenic roles of ghrelin; therefore, little is known about the kinetics of this peptide. Because the ester bond is both chemically and enzymatically unstable, elimination of the octanoyl modification of ghrelin can occur during storage, handling, and/or dissolution in culture medium (3). Because of increased interest in ghrelin measurements, a standardized method of sample collection is required.
In the present study, which focused on the active form of ghrelin, we investigated the effects of anticoagulants and storage conditions on ghrelin stability. To distinguish the active form of ghrelin, we established two ghrelin-specific RIAs; N-RIA recognizes the N-terminal, octanoyl-modified portion of the peptide, whereas C-RIA recognizes the C-terminal portion. Thus, the value determined by N-RIA specifically measures active ghrelin, whereas the value determined by C-RIA gives the total ghrelin immunoreactivity, including both active and desacyl ghrelin (4)(5)(6). The minimum detectable quantities in the N- and C-RIAs were 5.0 and 50 pmol/L, respectively. The respective intra- and interassay CV were 3% and 6% for the N-RIA and 6% and 9% for the C-RIA (n = 8 assays). Data are reported as the mean (SD). Comparisons of the time course of ghrelin concentrations between subgroups were made by two-way ANOVA for repeated measures, followed by the Scheffé test. P <0.05 was considered statistically significant.
All blood samples were taken from three healthy male volunteers who gave written informed consent. Blood
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  A. Stengel, D. Keire, M. Goebel, L. Evilevitch, B. Wiggins, Y. Tache, and J. R. Reeve Jr. The RAPID Method for Blood Processing Yields New Insight in Plasma Concentrations and Molecular Forms of Circulating Gut Peptides Endocrinology, November 1, 2009; 150(11): 5113 - 5118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Patterson, K. G. Murphy, S. R. Patel, N. A. Patel, H. C. Greenwood, J. H. Cooke, D. Campbell, G. A. Bewick, M. A. Ghatei, and S. R. Bloom Hypothalamic Injection of Oxyntomodulin Suppresses Circulating Ghrelin-Like Immunoreactivity Endocrinology, August 1, 2009; 150(8): 3513 - 3520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zheng, A. Dobner, R. Babygirija, K. Ludwig, and T. Takahashi Effects of repeated restraint stress on gastric motility in rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1358 - R1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aydin and E. Dag Does Ghrelin Really Increase in Epileptic Children Treated With Valproate? J Child Neurol, September 1, 2008; 23(9): 1084 - 1084. [PDF]
|
|
|
|
 |
|
 J. Roper, F. Francois, P. L. Shue, M. S. Mourad, Z. Pei, A. Z. Olivares de Perez, G. I. Perez-Perez, C.-H. Tseng, and M. J. Blaser Leptin and Ghrelin in Relation to Helicobacter pylori Status in Adult Males J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2350 - 2357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ariga, K. Imai, C. Chen, C. Mantyh, T. N. Pappas, and T. Takahashi Does ghrelin explain accelerated gastric emptying in the early stages of diabetes mellitus? Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1807 - R1812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, C. E. Prudom, R. Nass, S. S. Pezzoli, M. C. Oliveri, M. L. Johnson, P. Veldhuis, D. A. Gordon, A. D. Howard, D. R. Witcher, et al. Novel Ghrelin Assays Provide Evidence for Independent Regulation of Ghrelin Acylation and Secretion in Healthy Young Men J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1980 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lanyi, A. Varnagy, K. A Kovacs, T. Csermely, M. Szasz, and I. Szabo Ghrelin and acyl ghrelin in preterm infants and maternal blood: relationship with endocrine and anthropometric measures Eur. J. Endocrinol., January 1, 2008; 158(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gauna, P. Uitterlinden, P. Kramer, R. M. Kiewiet, J. A. M. J. L. Janssen, P. J. D. Delhanty, M. O. van Aken, E. Ghigo, L. J. Hofland, A. P. N. Themmen, et al. Intravenous Glucose Administration in Fasting Rats Has Differential Effects on Acylated and Unacylated Ghrelin in the Portal and Systemic Circulation: A Comparison between Portal and Peripheral Concentrations in Anesthetized Rats Endocrinology, November 1, 2007; 148(11): 5278 - 5287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gauna, R. M. Kiewiet, J. A. M. J. L. Janssen, B. van de Zande, P. J. D. Delhanty, E. Ghigo, L. J. Hofland, A. P. N. Themmen, and A. J. van der Lely Unacylated ghrelin acts as a potent insulin secretagogue in glucose-stimulated conditions Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E697 - E704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ando, Y. Ichimaru, F. Konjiki, M. Shoji, and G. Komaki Variations in the preproghrelin gene correlate with higher body mass index, fat mass, and body dissatisfaction in young Japanese women Am. J. Clinical Nutrition, July 1, 2007; 86(1): 25 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Broom, D. J. Stensel, N. C. Bishop, S. F. Burns, and M. Miyashita Exercise-induced suppression of acylated ghrelin in humans J Appl Physiol, June 1, 2007; 102(6): 2165 - 2171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rauh, M. Groschl, and W. Rascher Simultaneous Quantification of Ghrelin and Desacyl-Ghrelin by Liquid Chromatography-Tandem Mass Spectrometry in Plasma, Serum, and Cell Supernatants Clin. Chem., May 1, 2007; 53(5): 902 - 910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ferrero, P. Anserini, V. Remorgida, G. Bentivoglio, and N. Ragni Total and active ghrelin levels in women with polycystic ovary syndrome. Hum. Reprod., February 1, 2006; 21(2): 565 - 565. [Full Text] [PDF]
|
|
|
|
 |
|
 N Govoni, R De Iasio, C Cocco, A Parmeggiani, G Galeati, U Pagotto, C Brancia, M Spinaci, C Tamanini, R Pasquali, et al. Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts J. Endocrinol., September 1, 2005; 186(3): 505 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Groschl, H. G. Topf, J. Bohlender, J. Zenk, S. Klussmann, J. Dotsch, W. Rascher, and M. Rauh Identification of Ghrelin in Human Saliva: Production by the Salivary Glands and Potential Role in Proliferation of Oral Keratinocytes Clin. Chem., June 1, 2005; 51(6): 997 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kojima and K. Kangawa Ghrelin: Structure and Function Physiol Rev, April 1, 2005; 85(2): 495 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Patterson, K. G. Murphy, C. W. le Roux, M. A. Ghatei, and S. R. Bloom Characterization of Ghrelin-Like Immunoreactivity in Human Plasma J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2205 - 2211. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
